Wednesday, February 15, 2023 11:15:38 AM
It was tempting - the PPS- but I suspected as well the .03-.04 was way over priced. I was spot on correct. Crazy as that sounds - gut feeling as well.
Your def sitting well with free shares but a new investor looks at this differently. Why not instead plow $ into a monthly dividend that pays .10 either quarterly or monthly that trades from $3-6...make more money and it’s not going to do what this did- stop paying with snap of a finger. Leaving potential shareholders with a major 65- 75% loss, had they dropped in entry at .04? Plus no divs?
It had some potential - but the trust isn’t perpetual in nature, however, the lack of forthcoming information on what comes next in regards to this so called Highlander onshore well/ there’s zero guarantees this trust will do anything with that.
We don’t know if subin was doing all that dumping and many many others it’s a major red flag - if any filings come out in the future produce that knowledge then it’ll shine a light. But one thing is for sure/ lot of major holders of this likely did.
There’s likely quite a few newer investors from the last 1 year or so, found this, held it, and imo just lost their butts on this, and speculated and just lost a ton of investment money that gambled and stumbled onto this.
They were attracted to the low PPS and the divs were restarted- without looking at underlying factors. Pretty sad what occurred to those that invested and gambled. Because there’s no way those divs equal what they paid at a higher pps.
I don’t see this as a positive either with recent speculative trading range over .01 to .014-0.15 is even close to what’s it’s worth. Imo- this is sub Penny and we’re talking .005 likely imo. How did buying at .04 now being forced to sell hair over a Penny was a great deal for new shareholders?
Just my 2 cents. Mav.
Recent GULTU News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 08:59:57 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 08:11:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 08:15:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:05:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/14/2023 08:03:29 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM